Your Partner in Strategic Communications, Corporate Affairs, & Content Creation
Building Powerful Reputations
At Damouni Group, we leverage over 20 years of experience in media, investor relations, patient advocacy, and other key areas to empower healthcare and life science companies in building robust reputations.
Our philosophy is that traditional publicity and media relations have evolved to provide a cross-functional approach with several stakeholders in mind. We emphasize shared metrics and senior counsel during significant moments in a company’s life cycle.
Our Services
We are an advisory group-style agency that empowers clients to successfully navigate their needs. These are the critical core offerings required to build a comprehensive plan.
Our services encompass a wide range of strategic communications needs, including product launches, regulatory affairs, M&A support, issues and crisis management, advocacy, and public policy initiatives.
Strategic Communications
Public Relations
Executive Visibility
Crisis and Issues Management
Media Coaching and
Media Relations
Change Management and
Employee Engagement
Financial Communications
Corporate Affairs
CEO & C-Suite Strategic Counsel
Investor Relations
Patient Advocacy
Public Policy Mapping
Content Creation
Storytelling and Narrative
Development
Digital and Branding Strategy
Our Founding Partner
Damouni Group was founded on the principle of combining Sasha Damouni Ellis’s 20+ years of experience as a prominent healthcare business journalist and corporate communications officer. Sasha provides life science executives with communication expertise focused on stakeholders and metrics, with the goal of achieving their business objectives. Most recently, Sasha served as Chief Corporate Affairs Officer at immunology company, Vir Biotechnology, and as Senior Vice President, Corporate Affairs and Investor Relations at Marinus Pharmaceuticals, dedicated to treatments for seizure disorders. She also led external communications and media relations at Bayer U.S., executing brand-building campaigns in oncology, hemophilia, cardio-pulmonary, and women’s health. Earlier in her career, Sasha was a Healthcare Journalist at Bloomberg News and Global Editor of BioPharm Insight, formerly a division of the Financial Times Group, which she launched in New York and London.
